3rd Annual Epigenetics Discovery Congress is organized by MarketsandMarkets(MnM) Research Private Ltd and would be held during Oct 12 - 13, 2017 at Radisson Blu Edwardian Heathrow Hotel, London, England, United Kingdom.
The target audience for this medical event for Heads, Directors, Group Leaders, Professors, Lecturers, Research Associates, Scientists, Investigators, Fellows, Readers from Pharmaceutical, Bio-pharmaceutical and Research Institutes working in Epigenetics, Epidemiology, Medicinal Chemistry, Medicine, Genetics and Genomics, Developmental Genetics, Organic Chemistry, Natural Sciences, Translational sciences/medicines
This Conference will present novel research and address challenges right from the molecular sciences & disease diagnosis to drug discovery streams. The congress will also be a great platform to learn about novel technologies like next generation sequencing and single cell analysis.
Key Highlights:
• Transgenerational Epigenetics
• Epigenetic modifications
• Epigenetic infrastructure
• Novel epigenetic targets and combinations
• Therapeutic Implications
• Methylation in Disease processes
• Single cell epigenetics, epigenetic editing and novel technologies.
Additional details will be posted as soon as they are available.